Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Prime Solution on Fluid Balance After Open Heart Surgery
NCT00797589Phase 4Completed
- Sponsor
- University of Helsinki
- Start
- Jan 2009
- Primary completion
- Sep 2012
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 4 trial of hydroxyethyl starch 130/0.42 in valvular heart disease (VHD), coronary artery disease (CAD), sponsored by University of Helsinki. Started Jan 2009; status: completed.
02
Drugs
hydroxyethyl starch 130/0.42
03
Conditions
valvular heart disease (VHD)coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00797589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00797589.